Geoff Noller – Ibogaine Treatment for Opioid Dependence in New Zealand
Geoff Noller – Ibogaine Treatment for Opioid Dependence in New Zealand: A 12-month Post-treatment Follow-up Observational Study
(Kicking Against the Pricks – Ibogaine Therapy in Aotearoa)
About: This presentation reports on outcomes from a 12-month, post-treatment observational study of opioid dependent subjects, who have received ibogaine therapy. Outcome measures include the Addictions Severity Index (ASI) and the Beck Depression Inventory (BDI-II). The background to ibogaine treatment in New Zealand ...
Continue Reading →Parkinsons and Ibogaine
This shows ibogaine GDNF effect.
source
Ibogaine and 5-MeO-DMT – Christopher Ryan, PHD discusses with Crossroads Ibogaine
Crossroad’s own Martin Polanco and Maria Teresa talk on Christopher Ryan, PhD’s podcast talking about Crossroads Ibogaine treatment and 5-MeO-DMT.
Ibogaine is not a scheduled drug in Mexico which allows us to treat patients with Ibogaine. DMT falls under this same category. Ibogaine works in the brain to help eliminate withdrawals in addicts. This is what make Ibogaine such an effective treatment for addiction.
We follow up our ...
Continue Reading →Claudio Naranjo @ Global Ibogaine Conference 2016
Palestra do psiquiatra Chileno Claudio Naranjo encerrando a Conferência Mundial de ibogaína, em Tepoztlán, México. Naranjo é um dos pioneiros no estudo dos psicodélicos, incluindo ayahuasca, LSD e ibogaína.
Chilean psychiatrist Claudio Naranjo’s closing lecture at the Global Ibogaine Conference 2016, in Tepoztlan, Mexico. Naranjo is on of the pioneers in psychedelics research, including ayahuasca, LSD and ibogaine.
source